Cynthia Egan, Director at BlackRock Science & Technology Trust II (BSTZ), bought 3,122 shares at $37.32 ($117K) on 2020-12-21, disclosed to the SEC on 2020-12-23.
Open-market purchase of $117k BSTZ by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.32 | 1,561 | $58K | 50.0% |
| 2 | $37.32 | 1,561 | $58K | 50.0% |
| Total | $37.32 avg | 3,122 | $117K | 100% |
| Filing → |
| BMEZ | BUY | 2020-12-23 | $116K | — | Filing → |
| BGY | BUY | 2020-12-23 | $58K | — | Filing → |
| BME | BUY | 2019-07-02 | $291K | — | Filing → |